BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumar A, Narayan RK, Kulandhasamy M, Prasoon P, Kumari C, Kumar S, Pareek V, Sesham K, Shekhawat PS, Kant K, Kumar S. COVID-19 pandemic: insights into molecular mechanisms leading to sex-based differences in patient outcomes. Expert Rev Mol Med 2021;23:e7. [PMID: 34340720 DOI: 10.1017/erm.2021.9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Singh P, Bhaskar Y, Verma P, Rana S, Goel P, Kumar S, Gouda KC, Singh H. Impact of comorbidity on patients with COVID-19 in India: A nationwide analysis. Front Public Health 2022;10:1027312. [PMID: 36777781 DOI: 10.3389/fpubh.2022.1027312] [Reference Citation Analysis]
2 Kumar A, Asghar A, Raza K, Narayan RK, Jha RK, Satyam A, Kumar G, Dwivedi P, Sahni C, Kumari C, Kulandhasamy M, Motwani R, Kaur G, Krishna H, Sesham K, Pandey SN, Parashar R, Kant K, Kumar S. The shift in demographic involvement and clinical characteristics of COVID-19 from wild-type to Delta variant: A bioinformatic analysis of SARS-CoV-2 genomic sequence metadata from the Indian population (Preprint).. [DOI: 10.2196/preprints.44492] [Reference Citation Analysis]
3 Pacheco NL, Noren Hooten N, Zhang Y, Prince CS, Mode NA, Ezike N, Becker KG, Zonderman AB, Evans MK. Sex-specific transcriptome differences in a middle-aged frailty cohort. BMC Geriatr 2022;22:651. [PMID: 35945487 DOI: 10.1186/s12877-022-03326-7] [Reference Citation Analysis]
4 Russo P, Tacconelli E, Olimpieri PP, Celant S, Colatrella A, Tomassini L, Palù G. Mortality in SARS-CoV-2 Hospitalized Patients Treated with Remdesivir: A Nationwide, Registry-Based Study in Italy. Viruses 2022;14:1197. [DOI: 10.3390/v14061197] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zhang J, Shu T, Zhu R, Yang F, Zhang B, Lai X. The Long-Term Effect of COVID-19 Disease Severity on Risk of Diabetes Incidence and the Near 1-Year Follow-Up Outcomes among Postdischarge Patients in Wuhan. JCM 2022;11:3094. [DOI: 10.3390/jcm11113094] [Reference Citation Analysis]
6 Kingery JR, Safford MM, Martin P, Lau JD, Rajan M, Wehmeyer GT, Li HA, Alshak MN, Jabri A, Kofman A, Babu CS, Benitez EK, Palacardo F, Das IG, Kaylor K, Woo KM, Roberts NL, Rahiel S, Gali V, Han L, Lee J, Roszkowska N, Kim YE, Bakshi S, Hogan C, McNairy M, Pinheiro LC, Goyal P. Health Status, Persistent Symptoms, and Effort Intolerance One Year After Acute COVID-19 Infection. J Gen Intern Med 2022;37:1218-25. [PMID: 35075531 DOI: 10.1007/s11606-021-07379-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 17.0] [Reference Citation Analysis]
7 Ayana GM, Merga BT, Birhanu A, Alemu A, Negash B, Dessie Y. Predictors of Mortality Among Hospitalized COVID-19 Patients at a Tertiary Care Hospital in Ethiopia. Infect Drug Resist 2021;14:5363-73. [PMID: 34938084 DOI: 10.2147/IDR.S337699] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Kumar A, Parashar R, Kumar S, Faiq MA, Kumari C, Kulandhasamy M, Narayan RK, Jha RK, Singh HN, Prasoon P, Pandey SN, Kant K. Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19. J Med Virol 2021. [PMID: 34811761 DOI: 10.1002/jmv.27467] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
9 Kumar A, Narayan RK, Prasoon P, Kumari C, Kaur G, Kumar S, Kulandhasamy M, Sesham K, Pareek V, Faiq MA, Pandey SN, Singh HN, Kant K, Shekhawat PS, Raza K, Kumar S. COVID-19 Mechanisms in the Human Body-What We Know So Far. Front Immunol 2021;12:693938. [PMID: 34790191 DOI: 10.3389/fimmu.2021.693938] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
10 Kumar A, Asghar A, Raza K, Narayan RK, Jha RK, Satyam A, Kumar G, Dwivedi P, Sahni C, Kumari C, Kulandhasamy M, Motwani R, Kaur G, Krishna H, Sesham K, Pandey SN, Parashar R, Kant K, Kumar S. Demographic characteristics of SARS-CoV-2 B.1.617.2 (Delta) variant infections in Indian population.. [DOI: 10.1101/2021.09.23.21263948] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]